Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 21, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Codiak Biosciences, Inc.
| 8.75K |
—
|
—
|
∞
| 8.75K |
Feb 16
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 16
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 13
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 26 - Oct 13
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Array Biopharma Inc
| -86.08K |
$48.00 |
—
| -100.00% |
0
|
Jul 30
| |||||||
Array Biopharma Inc
| -11.71K |
$12.79 | -$1,788,091.00 | -28.04% | 30.06K |
Feb 6 - Feb 7
|
Scheduled
| ||||||
Array Biopharma Inc
| 6.38K |
$15.97 | -$79,993.73 | +18.02% | 41.77K |
Dec 14 - Dec 16
| |||||||
Array Biopharma Inc
| -20.00K |
$13.92 | -$278,400.00 | -36.11% | 35.39K |
Aug 15
|
Scheduled
| ||||||
Array Biopharma Inc
| 26.52K |
$9.32 | -$177,500.75 | +91.88% | 55.39K |
Jul 30
|
Scheduled
| ||||||
Array Biopharma Inc
| 6.53K |
$8.75 | -$50,100.75 | +29.20% | 28.87K |
Jan 16
|
Scheduled
| ||||||
Array Biopharma Inc
| 2.34K |
$10.92 | -$22,320.48 | +11.72% | 22.34K |
Dec 16
| |||||||
Array Biopharma Inc
| 20K |
$3.77 | $75,400.00 |
∞
| 20K |
Aug 14
| |||||||
Array Biopharma Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 27
| |||||||
Array Biopharma Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||